Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) FCF Margin (2016 - 2025)

Regenxbio (RGNX) has 12 years of FCF Margin data on record, last reported at 169.01% in Q4 2025.

  • For Q4 2025, FCF Margin fell 1485.0% year-over-year to 169.01%; the TTM value through Dec 2025 reached 73.25%, up 13743.0%, while the annual FY2025 figure was 73.25%, 13743.0% up from the prior year.
  • FCF Margin reached 169.01% in Q4 2025 per RGNX's latest filing, up from 189.86% in the prior quarter.
  • Across five years, FCF Margin topped out at 82.0% in Q4 2021 and bottomed at 447.99% in Q1 2023.
  • Average FCF Margin over 5 years is 207.21%, with a median of 202.54% recorded in 2021.
  • Peak YoY movement for FCF Margin: tumbled -22506bps in 2022, then skyrocketed 39518bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 82.0% in 2021, then tumbled by -274bps to 143.06% in 2022, then crashed by -32bps to 188.57% in 2023, then grew by 18bps to 154.16% in 2024, then decreased by -10bps to 169.01% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 169.01% in Q4 2025, 189.86% in Q3 2025, and 232.84% in Q2 2025.